SA
Go ProLog In
BTMD
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
7 analysts·Limited coverage
71
Score
6 Buy (86%)1 Hold (14%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
686%
Hold
114%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.50
+26.9%
Consensus
$3.25
+65.0%
Bull
$4.00
+103.0%
12-Month Target Range7 analysts
$2.50$3.25$4.00
Current $1.97Consensus
Current Price
$1.97
Upside to Consensus
$1.28

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+6.69%
EPS+28.32%
FY2028
Rev+6.10%
EPS+68.28%
FY2029
Rev+6.48%
EPS+6.56%

Earnings Surprises

Recent Analyst Actions

Apr 16, 2026Truist Financial
Biote price target lowered to $4 from $5 at Truist
Target:$4.00
+99.0%from $2.01
Mar 12, 2026National Bank
biote Corp. (BTMD) PT Lowered to $2.50 at TD Cowen
Target:$2.50
+58.2%from $1.58
Jan 7, 2026Truist Financial
Biote price target lowered to $5 from $6 at Truist
Target:$5.00
+96.9%from $2.54
Jun 21, 2024Truist Financial
Truist Securities Reiterates Buy Rating on biote Corp. (BTMD)
Target:$9.00
+24.5%from $7.23
Mar 13, 2024Jefferies
biote Corp. (BTMD) PT Raised to $8.24 at Jefferies
Target:$8.24
+35.3%from $6.09

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance